SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Company Response from Antiaging Quantum Living (AAQL) — Jun 30, 2017

Antiaging Quantum Living Inc.
Date: June 30, 2017 · CIK: 0001672571 · Accession: 0001672571-17-000011

AI Filing Summary & Sentiment

File numbers found in text: 333-211051

Date
June 29, 2017
Author
President
Form
CORRESP
Company
Antiaging Quantum Living Inc.

Letter

CORRESP for the SEC letter of the Registration Satement on Form S-1

Achison INC CIK: 0001672571 3906 Main Street, 207

Flushing, NY11354

June 29, 2017

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Real Estate and Commodities

100 F Street, N.E.

Washington, DC 20549

Attention:

Folake Ayoola

Stacie Gorman

Paul Cline

Wilson Lee

Re: Achison Inc

Amendment No. 7 to Registration Satement on Form S-1

Filed May 18, 2017

File No. 333-211051

General

1. Please confirm that you reasonably expect to offer and sell the registered $99.9 billion shares of common stock in the next two years. Refer to Rule 415(a)(2).

Please see the amended contents on page 1 of Form S-1/A on June 29, 2017.

Please see the removed contents of the Undertakings on pages 29 of Form S-1/A on June 29, 2017.

2. Please revise to update the financial statements through the fiscal quarter ended March 31, 2017 in accordance to Rule 8-08 of Regulation S-X.

Please see the amended contents of the Financial Statement on pages 12 of Form S-1/A on June 29, 2017.

Exhibit 23

3. Please include updated consents from your independent accountants in your next preeffective amendment. Please be advised that the consents for the inclusion of the reports from your independent accountants in the registration statement prior to effectiveness should not be older than 30 days.

Please see Exhibits 23.1, 23.2 and 23.3 of Form S-1/A on June 29, 2017.

Wanjun Xie

Wanjun Xie President

Achison Inc

Date: June 29, 2017

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

CORRESP for the SEC letter of the Registration Satement on Form S-1

Achison INC
CIK: 0001672571
3906 Main Street, 207

Flushing, NY11354

June 29, 2017

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Real Estate and Commodities

100 F Street, N.E.

Washington, DC 20549

Attention:

     Folake Ayoola

     Stacie Gorman

     Paul Cline

     Wilson Lee

Re: Achison Inc

    Amendment No. 7 to Registration Satement on Form S-1

    Filed May 18, 2017

    File No. 333-211051

General

1. Please confirm that you reasonably expect to offer and sell the registered $99.9 billion shares of common stock in the next two years. Refer to Rule 415(a)(2).

Please see the amended contents on page 1 of Form S-1/A on June 29, 2017.

Please see the removed contents of the Undertakings on pages 29 of Form S-1/A on June 29, 2017.

2. Please revise to update the financial statements through the fiscal quarter ended March 31, 2017 in accordance to Rule 8-08 of Regulation S-X.

Please see the amended contents of the Financial Statement on pages 12 of Form S-1/A on June 29, 2017.

Exhibit 23

3. Please include updated consents from your independent accountants in your next preeffective amendment.   Please be advised that the consents for the inclusion of the reports from your independent accountants in the registration statement prior to effectiveness should not be older than 30 days.

Please see Exhibits 23.1, 23.2 and 23.3 of Form S-1/A on June 29, 2017.

Wanjun Xie

Wanjun Xie
President

Achison Inc

Date: June 29, 2017